A team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified ...

A team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified a promising new drug target for acute myeloid leukemia (AML), a deadly ...

Acute myeloid leukemia is a type of cancer that starts inside bone marrow, the soft tissue inside bones that helps form blood cells. The cancer develops from myeloid blasts cells that would ...

However, it has proven difficult to identify such specific antigens in certain cancer types, including acute myeloid leukemia ...

Acute myeloid leukemia is often treated using RA-based ... They began producing well-known markers of maturation such as CD38 and CD11b, generated reactive oxygen species (ROS), and expressed ...

The first patient with relapsed or refractory acute myeloid leukemia has been dosed with Annamycin plus Cytarabine in the ...

This study reveals that the expression of the Src-family kinase (SFK), FGR, alone can induce cell differentiation similar to RA."BUFFALO, NY – March ...

All of the acute myeloid leukemia (AML) patients across both ... which targets B-cell maturation antigen (BCMA) for multiple ...

The journey of fighting Acute Myeloid Leukemia (AML) in India encompasses severe physical and emotional challenges for both patients and caregivers. Integrating mental health support into cancer ...